105 related articles for article (PubMed ID: 8230817)
21. Plasma concentration of human atrial natriuretic polypeptide in patients with impaired renal function.
Yamamoto Y; Higa T; Kitamura K; Tanaka K; Kangawa K; Matsuo H
Clin Nephrol; 1987 Feb; 27(2):84-6. PubMed ID: 2951044
[TBL] [Abstract][Full Text] [Related]
22. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
[TBL] [Abstract][Full Text] [Related]
23. Rubidium deficiency in dialysis patients.
Canavese C; DeCostanzi E; Branciforte L; Caropreso A; Nonnato A; Pietra R; Fortaner S; Jacono F; Angelini G; Gallieni M; Fop F; Sabbioni E
J Nephrol; 2001; 14(3):169-75. PubMed ID: 11439740
[TBL] [Abstract][Full Text] [Related]
24. Effect of haemodialysis on signal-averaged electrocardiogram P-wave parameters.
Jaroszyński AJ; Głowniak A; Sodolski T; Załuska W; Widomska-Czekajska T; Ksiazek A
Nephrol Dial Transplant; 2006 Feb; 21(2):425-30. PubMed ID: 16221710
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous determination of disopyramide and its mono-N-dealkylated metabolite enantiomers in human plasma and urine by enantioselective high-performance liquid chromatography.
Takahashi H; Tamura A; Ogata H; Masuhara K
J Chromatogr; 1990 Aug; 529(2):347-58. PubMed ID: 2229254
[TBL] [Abstract][Full Text] [Related]
26. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
27. Human pharmacokinetics and metabolism of disopyramide enantiomers.
Le Corre P; Gibassier D; Sado P; Le Verge R
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():233-7. PubMed ID: 1820885
[TBL] [Abstract][Full Text] [Related]
28. Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose.
Abe M; Kaizu K; Matsumoto K
Ther Apher Dial; 2007 Aug; 11(4):280-7. PubMed ID: 17661834
[TBL] [Abstract][Full Text] [Related]
29. Acute effects of intermittent hemodialysis and sustained low-efficiency hemodialysis (SLED) on the pulmonary function of patients under mechanical ventilation.
Steinhorst RC; Vieira JM; Abdulkader RC
Ren Fail; 2007; 29(3):341-5. PubMed ID: 17497449
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
[TBL] [Abstract][Full Text] [Related]
31. Cytokine production by mononuclear cells from patients with chronic renal failure.
Weinstein T; Fishman P; Djaldetti M; Levi J
Isr J Med Sci; 1993 Apr; 29(4):183-6. PubMed ID: 8491567
[TBL] [Abstract][Full Text] [Related]
32. Molecular forms of human brain natriuretic peptide (BNP) in plasma of patients on hemodialysis (HD).
Ishizaka Y; Yamamoto Y; Tanaka M; Kato F; Ishizaka Y; Yokota N; Kato J; Kitamura K; Eto T; Kangawa K
Clin Nephrol; 1995 Apr; 43(4):237-42. PubMed ID: 7606877
[TBL] [Abstract][Full Text] [Related]
33. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment.
Rysz J; Potargowicz E; Banach M; Luczyńska M; Stolarek R; Białasiewicz P; Kasielski M; Ciałkowska-Rysz A; Nowak D
Arch Immunol Ther Exp (Warsz); 2006; 54(5):347-55. PubMed ID: 17031465
[TBL] [Abstract][Full Text] [Related]
34. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
35. Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipients.
Haughey DB; Kraft CJ; Matzke GR; Keane WF; Halstenson CE
Am J Nephrol; 1985; 5(1):35-9. PubMed ID: 3881959
[TBL] [Abstract][Full Text] [Related]
36. Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine.
Lim VS; Fang VS; Katz AI; Refetoff S
J Clin Invest; 1977 Sep; 60(3):522-34. PubMed ID: 408377
[TBL] [Abstract][Full Text] [Related]
37. [Risk of arrhythmias in hemodialysis patients vs healthy people].
Milone F; Urso S; Garozzo M; Memeo AM; Volpe G; Battaglia G
G Ital Nefrol; 2004; 21 Suppl 30():S241-6. PubMed ID: 15750993
[TBL] [Abstract][Full Text] [Related]
38. The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis.
Don BR; Spin G; Nestorov I; Hutmacher M; Rose A; Kaysen GA
J Pharm Pharmacol; 2005 Nov; 57(11):1407-13. PubMed ID: 16259772
[TBL] [Abstract][Full Text] [Related]
39. In vitro assessment of stereoselective hepatic metabolism of disopyramide in humans: comparison with in vivo data.
Le Corre P; Ratanasavanh D; Chevanne F; Gibassier D; Sado P; Le Verge R; Guillouzo A
Chirality; 1991; 3(5):405-11. PubMed ID: 1756095
[TBL] [Abstract][Full Text] [Related]
40. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
